Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,827Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M243EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)23.8Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.5PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XLV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XLVKen Fisher 2016-03-31 Add$63.52 - $72.03
($67.02)
$ 70.856%Add 1.75%298,675
XLVKen Fisher 2015-12-31 Add$66.86 - $72.99
($70.76)
$ 70.850%Add 2.64%293,541
XLVKen Fisher 2015-09-30 Add$64.29 - $77.22
($73.06)
$ 70.85-3%Add 5.33%285,985
XLVLeon Cooperman 2015-06-30 Sold Out -0.42%$71.46 - $76.45
($73.85)
$ 70.85-4%Sold Out0
XLVKen Fisher 2015-06-30 Add$71.71 - $76.45
($74.07)
$ 70.85-4%Add 5.40%271,515
XLVLeon Cooperman 2015-03-31 Buy 0.42%$67.86 - $74.9
($71.15)
$ 70.85-0%New holding366,000
XLVKen Fisher 2015-03-31 Add$68.05 - $74.9
($71.32)
$ 70.85-1%Add 4.15%257,614
XLVKen Fisher 2014-06-30 Add0.01%$55.71 - $61.23
($58.7)
$ 70.8521%Add 34.36%226,412
XLVGeorge Soros 2012-09-30 Sold Out -0.03%$37.27 - $40.3
($38.73)
$ 70.8583%Sold Out0
XLVGeorge Soros 2012-06-30 Buy 0.03%$35.52 - $37.87
($36.91)
$ 70.8592%New holding50,000
XLVKen Fisher 2012-06-30 Add$35.52 - $37.87
($36.91)
$ 70.8592%Add 53.52%119,754
XLVKen Fisher 2011-06-30 Buy 0.01%$33.28 - $36.42
($34.99)
$ 70.85102%New holding86,997
XLVGeorge Soros 2011-03-31 Sold Out $31.5 - $33.18
($32.33)
$ 70.85119%Sold Out0
XLVGeorge Soros 2010-12-31 Reduce-0.15%$30.19 - $31.78
($31.13)
$ 70.85128%Reduce -93.88%34,153
XLVGeorge Soros 2010-09-30 Buy 0.25%$28.03 - $30.68
($29.2)
$ 70.85143%New holding558,053
XLVGeorge Soros 2010-06-30 Sold Out $28.38 - $32.31
($30.13)
$ 70.85135%Sold Out0
XLVGeorge Soros 2010-03-31 Reduce$30.68 - $33
($31.72)
$ 70.85123%Reduce -43.59%6,600
XLVGeorge Soros 2009-12-31 Buy 0.01%$28.07 - $31.62
($30.04)
$ 70.85136%New holding11,700
XLVBill Gates 2009-06-30 Sold Out -4.19%$23.76 - $26.53
($25.04)
$ 70.85183%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XLV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XLV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Atkinson, Richard Collier10% Security Holder 2016-05-06Buy169,000$0.0888462.5view
Reeson, DouglasDirector, Senior Officer 2016-05-06Buy100,000$0.03236066.67view
Crossett, Paul Everett10% Security Holder 2016-05-06Buy61,000$155-54.29view
Bal, Jatinder SinghIssuer 2016-05-06Sell20,000$0.06117983.33view
Bowerman, GordonDirector 2016-05-05Buy5,000$1.076521.5view
Yamini, BahmanDirector, Senior Officer 2016-05-03Buy5,000$0.2330704.35view
Buskard, James LivingstoneSenior Officer 2016-05-02Sell50,000$0.5512781.82view
Bal, Jatinder SinghDirector 2016-05-02Sell125,000$0.170750view
Bal, Jatinder SinghIssuer 2016-05-02Sell30,000$0.05141600view
Dubuc, PhilippeSenior Officer 2016-04-08Buy1,700$1.993460.3view

Quarterly/Annual Reports about XLV:

    News about XLV:

    Articles On GuruFocus.com
    S&P 500 Sector ETFs: A Look Under the Hood, Part 3 Mar 11 2015 
    Build a “Whatever Happens” Portfolio – Now! Aug 15 2014 
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    What Made McKesson the Top Gainer among Biotech Large-Caps? May 26 2016
    'Artificial' rates keeps investors in equities: Jim Pauls... May 26 2016
    Richard Bernstein: Corporate Profit Cycle May Be Turning May 24 2016
    SPDR Indices Rally as New Homes Sales Hit an 8-Year High May 24 2016
    Healthcare ETFs Could Be Second Half Rebound Ideas May 24 2016
    ETF TMI: Latest ETF Launches, Transitions & Jumps May 20 2016
    Interest Rate Concerns Lead to Market Losses: How Did XLV React? May 19 2016
    The Reasons behind Merck’s Improving Profitability May 18 2016
    Inside Amgen’s Key Growth Drivers in 2016 May 18 2016
    Trump or Clinton: These ETFs to Face Same Fate May 18 2016
    What’s Driving Merck’s Animal Health Segment? May 16 2016
    The Zacks Analyst Blog Highlights: Health Care Select Sector SPDR Fund, First Trust NASDAQ Clean... May 16 2016
    Varian Releases Software, Gains 5 Days in a Row May 14 2016
    Otezla Captures Psoriasis and Psoriatic Arthritis Market Shares May 14 2016
    Foreign Stocks: Looking Beyond Index Valuations May 14 2016
    Inside XLV Large-Caps: Allergan Posts Strong 1Q16 Earnings May 11 2016
    XLV Gains May 10, Trades above Its 20-Day Moving Average May 11 2016
    Should You Sell in May and Go Away? May 11 2016
    What's working: Health care and energy May 10 2016
    Will Professional Arbitrageurs Set Up the St. Jude-Abbott Merger? May 09 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)